Advertisement

Picture biomindz Brand LSE Mainz Place to Biotech 650x100px
Organisation › Details

DeepCure Inc.

Deepcure was founded to accelerate breakthrough science, developed by world-leading AI engineers, data scientists, and biologists. Using an end-to-end drug discovery platform and automated robotic wet lab, the Company is developing a novel pipeline of precision small molecules across many different therapeutic indications. DeepCure’s founding team includes some of the industry’s preeminent researchers and technologists. Our vision is to use AI-driven discovery to create better small molecules therapeutics and faster cures for every disease-relevant protein target. DeepCure is based in Boston, MA. *

 

Period Start 2021-11-08 existent
Products Industry AI-based drug discovery / AI-based drug development
  Industry 2 small-molecule drug discovery technology
Person Person Schreiber, Kfir (DeepCure 202111 CEO + Co-Founder)
     
Region Region Boston, MA
  Country United States (USA)
  Street 100 City Hall Plaza
  City 02108 Boston, MA
    Address record changed: 2024-01-05
     
Basic data Employees n. a.
     
    * Document for »About Section«: DeepCure, Inc.. (11/8/21). "Press Release: DeepCure Closes $40M Series A Funding Led by Morningside Ventures". Boston, MA.
     
   
Record changed: 2024-04-14

Advertisement

Picture EBD Group Biotech Showcase 2025 San Francisco BTS25 650x200px

More documents for DeepCure Inc.


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

Picture biomindz TRON LSE Mainz Translation Cancer Immunotherapy 650x300px




» top